HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Ajanta Pharma Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 68 filings·Updated 7 Oct 2026
Showing 10 of 68 filings.
7 Oct 20261 filing
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:56View Source
30 Sept 20261 filing
Company UpdateGeneral

Ajanta Pharma reports FY2026 Sustainability Report: renewable energy expansion, emission reductions, and governance enhancements

Key ESG highlights

  • Renewable energy capacity reached 16.6 MW, supplying about one-third of total energy needs.
  • Scope 1 emissions fell to 3,363.93 tCO2e from 6,392; Scope 2 dropped to 46,575.74 tCO2e.
  • Targets: Scope 1 -70% by 2027; Scope 2 -50% by 2027; Scope 3 -15% by 2032.
  • Renewable energy contributed 86,539.92 GJ; total energy 354,866.99 GJ; energy intensity 0.00000651 GJ per turnover.
  • Water withdrawal 533,648.1 KL; 1.5 lakh KL conservation potential in Marathwada; Zero Liquid Discharge.
  • Total waste 3,466.42 MT; 2,888 MT recovered; 578.42 MT disposed; 99% hazardous waste co-processed.
  • 11,800 trees planted in FY2026; target 20,000 by FY2027; sites outside protected areas.
  • Zero fatalities and zero LTIs across 10,404 employees and 2,802 workers.
  • Board comprises eight directors; 50% independent; two women independent; ESG governance via Sustainability Council and CSR Committee.
  • Health initiatives reached 210,725 beneficiaries; education 135,383; sports 16,982; cataract surgeries 80,103.
Filed 09:27View Source
28 Sept 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ajanta Pharma promoter pledge released in three tranches to repay loan from Aditya Birla Capital Ltd

Release of pledge on promoter shares

  • Pledge release on 21-Sep-26 reduced encumbered promoter shares from 1,17,40,571 (9.40%).
  • Post-21-Sep-26 encumbered shares: 1,16,85,071 (9.35%).
  • Pledge release on 22-Sep-26 reduced encumbrance to 1,16,66,553 (9.34%).
  • Pledge release on 23-Sep-26 reduced encumbrance to 1,16,42,386 (9.32%).
  • Lender: Aditya Birla Capital Ltd; end-use: loan repayment.
  • Promoter: Aayush M Agrawal, trustee Aayush Agrawal Trust.
  • Initial promoter encumbrance: 1,41,12,924 promoter holding (11.29%).
  • Pre-release encumbrance by promoter group: 1,17,40,571 (9.40%).
  • Final encumbered holding after all releases: 1,16,42,386 (9.32%).
Filed 09:23View Source
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Ajanta Pharma Ltd — Trading Window closed from 01 October 2026 till 48 hours after declaration of Financial Results for the second quarter and half year ended 30 September 2026

Ajanta Pharma Ltd — Trading Window closed from 01 October 2026 till 48 hours after declaration of Financial Results for the second quarter and half year ended 30 September 2026

Filed 09:45View Source
18 Sept 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ajanta Pharma promoter pledge release on 17,36,353 shares to repay loan

Encumbrance release

  • Target company: Ajanta Pharma Limited.
  • Event: Release of pledge on promoter shares.
  • Shares released: 17,36,353.
  • Promoter: Aayush Agrawal, trustee Aayush Agrawal Trust.
  • Reason: loan repayment.
  • Promoter holding before release: 1,41,12,924 shares (11.29%).
  • Promoter holding after release: 1,34,76,924 shares (10.79%).
Filed 16:31View Source
31 Aug 20263 filings
Company UpdateAnalyst / Investor Meet

Ajanta Pharma Announces Schedule for Two Analyst/Investor Meetings in September 2026

Meeting Details

  • 16 September 2026: Jefferies India Forum; one-on-one; Oberoi, New Delhi.
  • 28 September 2026: PL Capital Mid & Small Cap Conference 2026; Trident, BKC.

Participants

  • No specific management participants named for the meetings.

Purpose

  • Analyst/Institutional investor meetings; discussions based on published information.
Filed 11:46View Source
Company UpdateCopy of Newspaper Publication

Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 10:15View Source
Company UpdateNewspaper Publication

Pls find enclosed newspaper publication for transfer of equity shares to IEPF.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 10:13View Source
27 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ajanta Pharma: Creation and release of pledge on promoter shares by Aayush Agrawal Trust

Encumbrance events on promoter shares

  • Pledge created on 21-Aug-26 on Ajanta Pharma Limited promoter shares for 9,20,000.
  • Lender for creation: 360 One Prime Ltd.
  • Post-creation encumbered shares: 1,34,76,924 (10.79%).
  • Promoter: Aayush Agrawal Trust, trustee.
  • Pledge released on 19-Aug-26 for repayment of loan of 9,76,000.
  • Lender for release: RBL Bank Ltd.
  • Post-release encumbered shares: 1,25,56,924 (10.05%).
  • Before events, encumbered: 1,25,56,924 shares (10.05%).
Filed 15:31View Source
19 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Promoter Ravi Agrawal releases pledge on 6,910 Ajanta Pharma shares (Excess Pledge)

Event Overview

  • Release of pledge on 6,910 Ajanta Pharma equity shares by promoter Ravi Agrawal (Excess Pledge).
Filed 17:41View Source
Showing 10 of 68 filings